Background: Allergic rhinitis (AR) is a multifocal IgE-mediated type I hypersensitivity reaction that affects sino-nasal mucosa and is characterized by excessive sneezing, watery rhinorrhea, nasal itching, nasal stuff...Background: Allergic rhinitis (AR) is a multifocal IgE-mediated type I hypersensitivity reaction that affects sino-nasal mucosa and is characterized by excessive sneezing, watery rhinorrhea, nasal itching, nasal stuffiness and eyes itching. Bronchial asthma (BA) is one of the common childhood diseases that affects the respiratory system characterized by recurrent cough, wheezing, chest tightness and difficulty with breathing. The two conditions are different manifestations of allergic disease of the airway;the composition of the inflammatory substrate in the mucosa of allergic patients is similar to the late-phase allergic response seen elsewhere in the respiratory tract, such as in bronchial asthma. Aim: The aim was to compare the impacts of allergic rhinitis and bronchial asthma on tympanometric parameters in children. Patients & Methods: This is a hospital based comparative cross-sectional study. Two groups of participants aged 4 - 12 years, one group with documented clinical diagnosis of allergic rhinitis and the other group with documented clinical diagnosis of bronchial asthma were consecutively selected from ear, nose and throat (ENT) and pediatrics cardiopulmonary outpatient clinics of Aminu Kano Teaching Hospital Kano respectively. Equal number of children aged 4 - 12 years with no history of ENT diseases or bronchial asthma that were selected from elementary schools within the same community served as a control group. An interviewer-administered questionnaire was filled out for all the participants, complete ENT and chest examinations were carried out and subsequently all the selected participants had tympanometry done, findings were recorded and analyzed. Results: The mean age of participants with bronchial asthma was found to be 7.5 ± 2.6 years while participants with allergic rhinitis had the mean age of 6.8 ± 2.1 years. The mean middle ear pressure (MEP) of participants with bronchial asthma was found to be -15.22 dapa and -40.32 dapa in those with allergic rhinitis. Acoustic reflex was found to be absent in 15.4% of the participants with bronchial asthma and 29.6% of allergic rhinitis participants. Type B tympanogram was found in 2.8% of bronchial asthma participants and 7.3% in participants with allergic rhinitis. Type C tympanogram was found in 4.6% of participants with bronchial asthma and 15.5% of participants with allergic rhinitis. Type A tympanogram was found in 90% of participants with bronchial asthma and 75% of participants with allergic rhinitis. The difference between type A, B and C tympanograms of participants with bronchial asthma and those with allergic rhinitis was found to be statistically significant (Type A χ<sup>2</sup> = 14.62, df = 4, p value = 0.01, Type B χ<sup>2</sup> = 14.06, df = 4, p value = 0.01, Type C χ<sup>2</sup> = 17.01, df = 6, p value = 0.01). Conclusion: Participants with allergic rhinitis were found to have more abnormalities of tympanometric parameters compared to participants with bronchial asthma which signifies allergic rhinitis conferred an increased risk of having middle ear diseases and otitis media with effusion compared to bronchial asthma.展开更多
Objective:To observe the application effect of pidotimod in the treatment of allergic rhinitis in children accompanied by allergic asthma.Methods:A total of 60 children with allergic rhinitis accompanied by allergic a...Objective:To observe the application effect of pidotimod in the treatment of allergic rhinitis in children accompanied by allergic asthma.Methods:A total of 60 children with allergic rhinitis accompanied by allergic asthma who were admitted in our hospital from January, 2013 to January, 2015 were included in the study and randomized into the treatment group and the control group with 30 cases in each group. The patients in the two groups were given routine treatments in combined with sublingual immunotherapy. On this basis, the patients in the treatment group were given additional pidotimod. The immunological function, inflammatory cytokine level, and pulmonary function improvement in the two groups were observed. Results:The immunological function, inflammatory cytokine level, and pulmonary function improvement in the treatment group were significantly superior to those in the control group. Conclusions:Pidotimod can significantly enhance the immunological function in children with allergic rhinitis in children accompanied by allergic asthma, alleviate the inflammatory reaction, and promote the pulmonary function improvement, with an accurate efficacy.展开更多
<strong>Background:</strong> Rhinopathy, a dysfunction or inflammation of the nasal mucosal lining, presents with symptoms of nasal obstruction, posterior and anterior rhinorrhea, sneezing, nasal itching, ...<strong>Background:</strong> Rhinopathy, a dysfunction or inflammation of the nasal mucosal lining, presents with symptoms of nasal obstruction, posterior and anterior rhinorrhea, sneezing, nasal itching, and hyposmia, with variations in symptom intensity in each subtype. Asthma originates from a combination of genetic and environmental factors. <strong>Objective:</strong> This study aimed to treat allergic rhinitis in patients with controlled asthma and to verify the behavior of the variables. <strong>Methods:</strong> In this prospective study, quantitative and qualitative assessment of rhinopathy in asthma was performed. Patients with symptoms of rhinopathy and controlled asthma, who were controlled with treatment at the pulmonology outpatient clinic of the Center for Medical Specialties at [hospital], were included. Patients were treated for 2 months according to the IV Rhinopathy Consensus. They underwent a pulmonary function test and completed a questionnaire before and after treatment for rhinopathy. <strong>Results:</strong> In total, 47 patients aged 7 - 12 years (9.30 ± 1.70 years;median 9 years) were evaluated, including 29 (61.7%) males and 18 (38.3%) females. Patients were evaluated at two timepoints, with an interval of 12 days to 14 months (3.81 ± 3.21 months;median 3 months), and were evaluated regarding the various characteristics of their allergy. <strong>Conclusion: </strong>The treatment of allergic rhinitis in patients with asthma resulted in an improvement in variables related to nasal congestion, rhinorrhea, cough, dyspnea, wheezing, and dyspnea on exertion, and maintaining physical activities without dyspnea.展开更多
目的探讨儿童过敏性鼻炎(allergic rhinitis,AR)和支气管哮喘(bronchial asthma,BA)患儿外周血高迁移率族蛋白B1(high mobility group box 1,HMGB1)水平与辅助性T细胞17(T helper 17 cell,Th17)和调节性T细胞(regulatory T cell,Treg)...目的探讨儿童过敏性鼻炎(allergic rhinitis,AR)和支气管哮喘(bronchial asthma,BA)患儿外周血高迁移率族蛋白B1(high mobility group box 1,HMGB1)水平与辅助性T细胞17(T helper 17 cell,Th17)和调节性T细胞(regulatory T cell,Treg)的比例(Th17/Treg)的相关性。方法采用前瞻性研究方法,选取2023年3月至12月在解放军总医院第七医学中心门急诊就诊患儿及健康体检者共113例作为研究对象,按照临床症状分成健康对照组(n=25)、过敏性鼻炎组(AR组,n=28)、支气管哮喘组(BA组,n=31)和两者并有组(AR+BA组,n=29),比较4组肺功能、免疫球蛋白E(immunoglobulin E,IgE)、白细胞介素(interleukin,IL)-17、HMGB1水平和Th17/Treg比例。统计学方法采用t检验、方差分析和Pearson相关性分析。结果各组的第1秒用力呼气容积(forced expiratory volume in the first second,FEV1)的结果显示,健康对照组高于AR组、BA组和AR+BA组[(96.4±2.5)%、(90.7±4.9)%、(88.6±4.1)%、(82.1±5.5)%,F=47.193,P值均<0.001],显示AR和BA患儿肺功能可能变差。AR组、BA组和AR+BA组HMGB1水平高于健康对照组[(30.4±12.4)mg/L、(47.2±17.8)mg/L、(51.4±21.8)mg/L、(4.3±2.1)mg/L,F=48.896,P值均<0.001]。AR组、BA组和AR+BA组Th17/Treg比例高于健康对照组(0.68±0.14、0.71±0.14、1.36±0.40、0.30±0.07,F=105.547,P值均<0.001)。Pearson相关性分析结果显示,HMGB1与Th17(r=0.521,P<0.001)、Th17/Treg(r=0.419,P<0.05)、IgE(r=0.502,P<0.05)、IL-17(r=0.472,P<0.05)呈正相关,与FEV1(r=-0.645,P<0.001)呈负相关。结论在儿童AR合并BA的发病过程中,HMGB1水平及Th17细胞百分比增加,而Treg细胞百分比降低,Th17/Treg比例存在失衡的情形,HMGB1水平与Th17细胞百分比、Th17/Treg比例、IgE、IL-17及FEV1存在一定的相关性,HMGB1和Th17/Treg的动态平衡可能通过影响细胞因子的表达而起到一定的调节作用。展开更多
文摘Background: Allergic rhinitis (AR) is a multifocal IgE-mediated type I hypersensitivity reaction that affects sino-nasal mucosa and is characterized by excessive sneezing, watery rhinorrhea, nasal itching, nasal stuffiness and eyes itching. Bronchial asthma (BA) is one of the common childhood diseases that affects the respiratory system characterized by recurrent cough, wheezing, chest tightness and difficulty with breathing. The two conditions are different manifestations of allergic disease of the airway;the composition of the inflammatory substrate in the mucosa of allergic patients is similar to the late-phase allergic response seen elsewhere in the respiratory tract, such as in bronchial asthma. Aim: The aim was to compare the impacts of allergic rhinitis and bronchial asthma on tympanometric parameters in children. Patients & Methods: This is a hospital based comparative cross-sectional study. Two groups of participants aged 4 - 12 years, one group with documented clinical diagnosis of allergic rhinitis and the other group with documented clinical diagnosis of bronchial asthma were consecutively selected from ear, nose and throat (ENT) and pediatrics cardiopulmonary outpatient clinics of Aminu Kano Teaching Hospital Kano respectively. Equal number of children aged 4 - 12 years with no history of ENT diseases or bronchial asthma that were selected from elementary schools within the same community served as a control group. An interviewer-administered questionnaire was filled out for all the participants, complete ENT and chest examinations were carried out and subsequently all the selected participants had tympanometry done, findings were recorded and analyzed. Results: The mean age of participants with bronchial asthma was found to be 7.5 ± 2.6 years while participants with allergic rhinitis had the mean age of 6.8 ± 2.1 years. The mean middle ear pressure (MEP) of participants with bronchial asthma was found to be -15.22 dapa and -40.32 dapa in those with allergic rhinitis. Acoustic reflex was found to be absent in 15.4% of the participants with bronchial asthma and 29.6% of allergic rhinitis participants. Type B tympanogram was found in 2.8% of bronchial asthma participants and 7.3% in participants with allergic rhinitis. Type C tympanogram was found in 4.6% of participants with bronchial asthma and 15.5% of participants with allergic rhinitis. Type A tympanogram was found in 90% of participants with bronchial asthma and 75% of participants with allergic rhinitis. The difference between type A, B and C tympanograms of participants with bronchial asthma and those with allergic rhinitis was found to be statistically significant (Type A χ<sup>2</sup> = 14.62, df = 4, p value = 0.01, Type B χ<sup>2</sup> = 14.06, df = 4, p value = 0.01, Type C χ<sup>2</sup> = 17.01, df = 6, p value = 0.01). Conclusion: Participants with allergic rhinitis were found to have more abnormalities of tympanometric parameters compared to participants with bronchial asthma which signifies allergic rhinitis conferred an increased risk of having middle ear diseases and otitis media with effusion compared to bronchial asthma.
文摘Objective:To observe the application effect of pidotimod in the treatment of allergic rhinitis in children accompanied by allergic asthma.Methods:A total of 60 children with allergic rhinitis accompanied by allergic asthma who were admitted in our hospital from January, 2013 to January, 2015 were included in the study and randomized into the treatment group and the control group with 30 cases in each group. The patients in the two groups were given routine treatments in combined with sublingual immunotherapy. On this basis, the patients in the treatment group were given additional pidotimod. The immunological function, inflammatory cytokine level, and pulmonary function improvement in the two groups were observed. Results:The immunological function, inflammatory cytokine level, and pulmonary function improvement in the treatment group were significantly superior to those in the control group. Conclusions:Pidotimod can significantly enhance the immunological function in children with allergic rhinitis in children accompanied by allergic asthma, alleviate the inflammatory reaction, and promote the pulmonary function improvement, with an accurate efficacy.
文摘<strong>Background:</strong> Rhinopathy, a dysfunction or inflammation of the nasal mucosal lining, presents with symptoms of nasal obstruction, posterior and anterior rhinorrhea, sneezing, nasal itching, and hyposmia, with variations in symptom intensity in each subtype. Asthma originates from a combination of genetic and environmental factors. <strong>Objective:</strong> This study aimed to treat allergic rhinitis in patients with controlled asthma and to verify the behavior of the variables. <strong>Methods:</strong> In this prospective study, quantitative and qualitative assessment of rhinopathy in asthma was performed. Patients with symptoms of rhinopathy and controlled asthma, who were controlled with treatment at the pulmonology outpatient clinic of the Center for Medical Specialties at [hospital], were included. Patients were treated for 2 months according to the IV Rhinopathy Consensus. They underwent a pulmonary function test and completed a questionnaire before and after treatment for rhinopathy. <strong>Results:</strong> In total, 47 patients aged 7 - 12 years (9.30 ± 1.70 years;median 9 years) were evaluated, including 29 (61.7%) males and 18 (38.3%) females. Patients were evaluated at two timepoints, with an interval of 12 days to 14 months (3.81 ± 3.21 months;median 3 months), and were evaluated regarding the various characteristics of their allergy. <strong>Conclusion: </strong>The treatment of allergic rhinitis in patients with asthma resulted in an improvement in variables related to nasal congestion, rhinorrhea, cough, dyspnea, wheezing, and dyspnea on exertion, and maintaining physical activities without dyspnea.
文摘目的探讨儿童过敏性鼻炎(allergic rhinitis,AR)和支气管哮喘(bronchial asthma,BA)患儿外周血高迁移率族蛋白B1(high mobility group box 1,HMGB1)水平与辅助性T细胞17(T helper 17 cell,Th17)和调节性T细胞(regulatory T cell,Treg)的比例(Th17/Treg)的相关性。方法采用前瞻性研究方法,选取2023年3月至12月在解放军总医院第七医学中心门急诊就诊患儿及健康体检者共113例作为研究对象,按照临床症状分成健康对照组(n=25)、过敏性鼻炎组(AR组,n=28)、支气管哮喘组(BA组,n=31)和两者并有组(AR+BA组,n=29),比较4组肺功能、免疫球蛋白E(immunoglobulin E,IgE)、白细胞介素(interleukin,IL)-17、HMGB1水平和Th17/Treg比例。统计学方法采用t检验、方差分析和Pearson相关性分析。结果各组的第1秒用力呼气容积(forced expiratory volume in the first second,FEV1)的结果显示,健康对照组高于AR组、BA组和AR+BA组[(96.4±2.5)%、(90.7±4.9)%、(88.6±4.1)%、(82.1±5.5)%,F=47.193,P值均<0.001],显示AR和BA患儿肺功能可能变差。AR组、BA组和AR+BA组HMGB1水平高于健康对照组[(30.4±12.4)mg/L、(47.2±17.8)mg/L、(51.4±21.8)mg/L、(4.3±2.1)mg/L,F=48.896,P值均<0.001]。AR组、BA组和AR+BA组Th17/Treg比例高于健康对照组(0.68±0.14、0.71±0.14、1.36±0.40、0.30±0.07,F=105.547,P值均<0.001)。Pearson相关性分析结果显示,HMGB1与Th17(r=0.521,P<0.001)、Th17/Treg(r=0.419,P<0.05)、IgE(r=0.502,P<0.05)、IL-17(r=0.472,P<0.05)呈正相关,与FEV1(r=-0.645,P<0.001)呈负相关。结论在儿童AR合并BA的发病过程中,HMGB1水平及Th17细胞百分比增加,而Treg细胞百分比降低,Th17/Treg比例存在失衡的情形,HMGB1水平与Th17细胞百分比、Th17/Treg比例、IgE、IL-17及FEV1存在一定的相关性,HMGB1和Th17/Treg的动态平衡可能通过影响细胞因子的表达而起到一定的调节作用。
文摘目的观察针药并用治疗儿童过敏性鼻炎-哮喘综合征(combined allergic rhinitis and asthma syndrome,CARAS)的临床疗效及对呼出气一氧化氮(fractional exhaled nitric oxide,FeNO)、1秒率[第1秒用力呼气容积(forced expiratory volume in the first second,FEV_(1))/用力肺活量(forced vital capacity,FVC)]、呼气峰流速(peak expiratory flow,PEF)的影响。方法将90例CARAS患者随机分3组,每组30例。对照1组采用沙美特罗替卡松气雾剂联合孟鲁司特钠治疗,对照2组采用针刺治疗,治疗组采用针刺联合沙美特罗替卡松气雾剂及孟鲁司特钠治疗。观察3组治疗前后中医证候积分、FeNO、FEV_(1)/FVC和PEF的变化,并比较3组临床疗效。结果治疗组临床疗效明显优于对照1组和对照2组(P<0.05)。治疗后,3组中医证候积分低于治疗前(P<0.05),治疗组中医证候积分治疗前后差值明显高于对照1组和对照2组(P<0.05);3组FeNO水平均降低(P<0.05),且治疗组低于对照1组和对照2组(P<0.05);3组FEV_(1)%及PEF水平均升高(P<0.05),且治疗组高于对照1组和对照2组(P<0.05)。结论针药并用可有效改善CARAS患者的气道炎症与肺功能,缓解症状与体征,临床疗效良好。
